Delivery Order SPE2DR25D1109-SPE2DR26FFL3K
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,494.83 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count package), with a completion date of September 22, 2025. This is a firm fixed price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $7,691.76 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count package). This competitively awarded, firm fixed-price delivery order was issued on December 30, 2025, with an ultimate completion date of December 31, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $13,867.55 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units). This firm fixed-price delivery order, executed on December 4, 2025, with completion targeted for December 5, 2025, represents a competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 23, 2026, for the supply of Rexulti 3 mg tablets in a quantity of 30 units, with a ceiling value of $1,472.28. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was competitively procured on a full and open basis. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and the delivery order is scheduled for...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,804.12 by the Defense Logistics Agency (DLA) for the supply of Rexulti 1 mg tablets in a 30-count quantity. The contract is a firm fixed-price delivery order with an ultimate completion date of October 27, 2025, and was awarded on October 24, 2025, without a set-aside designation, indicating competitive award to the contractor. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $17,662.12 to AmerisourceBergen Drug Corp for the supply of Rexulti 0.5 mg tablets (30-count units) under a firm fixed-price contract. The award was made on October 28, 2025, with an ultimate completion date of October 29, 2025. This non-competitive delivery order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,399.55 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed-price contract. This delivery order, issued on November 25, 2025, with an ultimate completion date of November 26, 2025, represents a non-set-aside competitive award to support federal medical supply needs. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $13,026.20 to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Rexulti 3 mg tablets (30-count units). This firm fixed-price, non-competitive delivery order is scheduled for completion by June 30, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $5,225.26 to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Rexulti 2 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, issued competitively under the company's existing indefinite delivery contract with DLA. The order is scheduled for completion by January 6, 2026, and will be fulfilled from AmerisourceBergen's corporate headquarters location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,585.67 to AmerisourceBergen Drug Corp for the supply of Rexulti 3 mg tablets (30-count units) under a firm fixed-price contract. The award was made on May 23, 2025, with an ultimate completion date of May 27, 2025, and was not set-aside for small business or other designated groups. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFL3KDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,768.58 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (quantity: 30-count packages) on January 23, 2026. This is a firm fixed-price delivery order with an ultimate completion date of January 26, 2026, and was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor and healthcare solutions provider serving federal agencies. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This prime IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications across multiple therapeutic domains and critical medical commodities such as specialty drugs, vaccines, and medical devices. The award demonstrates AmerisourceBergen's continued role as a key vendor in the federal medical procurement supply chain serving military treatment facilities and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.8k | 1/22/26 |